Compare Novo Nordisk A/S (NVO) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Skyworks Solutions Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Skyworks Solutions Inc trades at $62.81 (market cap $8.99B). The key difference: Novo Nordisk A/S is far larger — about 24.5× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.75%). Which is the better fit depends on your goals.
| NVO | SWKS | |
|---|---|---|
Market Cap | $220.53B | $8.99B |
Sector | Health | Technology |
52-Week High | $71.70 | $83.40 |
52-Week Low | $35.29 | $52.50 |
Enterprise Value | $239.49B | $8.76B |
Dividend Yield | 3.63% | 4.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
